Edward Cable

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis

Evaluation of Cryoglobulins

New therapies on the horizon for hepatitis C

Liver fibrosis

Autoimmune Thrombocytopenia Associated with Hepatitis C Virus Infection

Interferon-Induced Sarcoidosis

Hepatitis C Virus Infection Mimicking Primary Sjögren Syndrome

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses

Diagnosis and Management of Autoimmune Hepatitis

Type I interferons in infectious disease

Serum Soluble CD23 but Not IL8, IL10, GM-CSF, or IFN-γ Is Elevated in Patients with Hepatitis C Infection

Response to Hepatitis B Vaccine in HIV‐1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies

TFOS DEWS II pathophysiology report

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA

The long and winding road leading to the identification of the hepatitis C virus

HEPATITIS C–ASSOCIATED AUTOIMMUNE DISORDERS

Natural history of HCV infection

Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis

Extrahepatic manifestations of chronic hepatitis C

Autoimmunity in hepatitis C and D virus infection

Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation

Extrahepatic Manifestations Associated with Hepatitis C Virus Infection: A Prospective Multicenter Study of 321 Patients

Contribution of obesity to hepatitis C-related fibrosis progression

Sarcoidosis

Evidence‐based guidelines for the use of immunologic tests: Antinuclear antibody testing

Induction of Broad CD4⁺and CD8⁺T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5

Flying Under the Radar: The Immunobiology of Hepatitis C

Type I IFN Receptor Signals Directly Stimulate Local B Cells Early following Influenza Virus Infection

Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia

Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection

Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease

Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells

EASL Recommendations on Treatment of Hepatitis C 2018

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders

Hepatitis C: A review and update

Systemic lupus erythematosus after α-Interferon therapy for chronic hepatitis C: a case report and review of the literature

Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients

Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand

Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response

High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C†